These findings suggested SAB treatment inhibited EZH2 and H3k27me3 through regulating PTEN/AKT signaling pathway, subsequently decreased the expression of FN and α-SMA to suppressed the renal fibrosis and improve renal function. The gene discussed is EZH2; the disease is renal fibrosis.